Trial of Oxaloacetate in Alzheimer's Disease (TOAD)
NCT02593318
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
OTHER
Sponsor class
Conditions
Alzheimer's Disease (AD)
Interventions
DRUG:
Oxaloacetate (OAA) 1g
DRUG:
Oxaloacetate (OAA) 2g
Sponsor
Russell Swerdlow